Clinical trial
Contrast-enhanced Ultrasound for Follow-up After Radiofrequency Ablation of Renal Lesions: a Prospective, Blinded Study
NCT01141816 is registered in ClinicalTrials.gov with St. Joseph's Healthcare Hamilton as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Contrast-enhanced Ultrasound for Follow-up After Radiofrequency Ablation of Renal Lesions: a Prospective, Blinded Study
- Lead sponsor
- St. Joseph's Healthcare Hamilton
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- January 31, 2015
- Completion date
- January 31, 2022
- Enrollment
- 30 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.